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Abstract  
Introduction: breast cancer is the most common cancer in women in Indonesia. Patients' survival depends on various factors, namely patient-, 
tumor-, and treatment-related factors. Survival analysis on Indonesian patients has only been reported in a few studies. This study aimed to identify 
the factors that are associated with five-year overall survival (OS) among patients with breast cancer at a local tertiary hospital in Indonesia. 
Methods: a retrospective cohort study was conducted at Dr Sardjito Hospital, Yogyakarta. Female patients diagnosed with breast cancer between 
January and December 2009 were studied. Socio-demographic and clinicopathological data were collected from the medical and pathological records. 
The five-year OS rate was assessed using Kaplan Meier method and prognostic factors were analyzed using Cox regression. Results: a total of 213 
eligible patients with breast cancer were recruited. The five-year OS probability of the breast cancer patient was 51.07%. The majority of the patients 
(151, 70.9%) presented an advanced stage at the time of diagnosis. In the bi-variable analysis, cases who were younger, of a lower educational 
status, at a more advanced stage, with a bigger tumor size, and a central tumor location showed a worse five-year OS compared to their counterparts 
(p = 0.005, 0.001, 0.004, 0.011 and 0.023, respectively). In the multivariable analysis, age was an independent predictor for the OS (HR = 3.73; 
95% CI = 1.0-13.6, p = 0.046). Conclusion: the five-year OS of breast cancer patients in the local tertiary hospital was 51.07%. The patients' age 
at diagnosis was the only significant prognostic factor for the patients' survival. 
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Introduction 
 
Breast cancer is the most common cancer diagnosed among women 
worldwide. Since 2008, the incidence of breast cancer has increased 
by > 20%, with an estimated 1.67 million of new breast cancer 
patients diagnosed in 2012. The majority of these cases occur in 
populations living in less developed regions. This malignancy ranks as 
the fifth most frequent cause of mortality among all types of cancers, 
with 522,000 deaths. It is the most frequent cause of cancer death in 
women from less developed countries (324,000 deaths) and the 
second most frequent cause of cancer death in more developed 
countries (198,000 deaths), after lung cancer [1, 2]. Breast cancer is 
a major public health problem in developing countries with limited 
resources, like Indonesia [3, 4]. Based on GLOBOCAN data, breast 
cancer in Indonesia is the most common cancer in women with an 
age-standardized incidence of 40.3/100,000 [1]. Data from the 
Jakarta Population-Based Cancer Registry (PBCR), that acted as a 
source for GLOBOCAN's data, showed that breast cancer was the top 
leading malignancy among Indonesian females from 2005 to 2007, 
followed by cervical cancer, ovarian cancer, colorectal cancer, 
bronchus and lung cancer, thyroid cancer, corpus uteri cancer, 
pharyngeal cancer, leukemia, and liver cancer [4]. According to the 
Health Ministry of Indonesia, the high incidence of advanced disease 
and mortality in breast cancer is due to the lack of a screening 
program, and poor access to, or the availability of, treatment. Most 
breast cancer patients seek healthcare only when they have 
symptoms and are diagnosed as being at an advanced stage [5]. 
Indeed, only 5% of women in developing countries like Indonesia 
were screened compared to 40% in advanced countries [6]. The 
survival of patients with breast cancer depends on many factors. 
Demographic variables such as age [7-10], educational level [11], 
financial status [12], family history [13] and marital status [14, 15] 
have been found to influence the survival rate. Tumor and 
clinicopathological parameters that have been observed to impact on 
survival include tumor size, nodal status, the presence of metastatic 
disease, the clincal stage, tumor location, histology grade, and the 
presence of comorbidities [9, 16-19]. Treatment factors that relate to 
the survival rate include the completeness of the approaches to 
treatment and surgical intervention [20, 21]. In fact, there are only a 
few reports of factors impacting on the survival of Indonesian women 
with breast cancer [8, 9, 22, 23]. Thus, the aim of the study was to 
identify the factors associated with the five-year overall survival (OS) 
among breast cancer patients at a local hospital. Analyzing the key 
factors would be of great use in identifying individuals at high risk of 
mortality and planning appropriate interventions. 
  
  
Methods 
 
A retrospective cohort study was conducted at Dr Sardjito Hospital, 
which functions as a tertiary referral hospital in Yogyakarta, 
Indonesia. We included female breast cancer patients who were 
diagnosed in 2009. The patients were treated according to the 
standard protocol and prospectively followed to assess their survival 
over a period of five years. Details of the patients' information were 
extracted from the medical and pathological records, either from the 
medical records central unit, the cancer clinic, or the pathology 
laboratory. The following relevant data were collected: age at 
diagnosis, socio-demographic details (marital and educational status), 
family history of breast cancer, pathological diagnosis, clinical stage, 
tumor size, histology type, tumor location, comorbidity, and 
treatment. The survival status of the patients was obtained from the 
medical records at the end of five years of diagnosis. Telephone 
interviews were conducted for those who did not have life status in 
the medical records. A core family member of the patient was 
considered as a respondent if the patient had passed away. A semi-
structured questionnaire was used. Data was considered as missing 
if the authors could not collect the life status data from medical 
records or had no response from three attempts to contact the 
patient. The patient characteristics were described as percentages. 
Kaplan-Meier constructs were conducted to estimate OS rates. The 
survival time of a patient referred to the number of months from the 
date of diagnosis to the date of the patient died, date of loss to follow-
up, or date of the end of the study for patients who were still alive. 
All data were analyzed using STATA. Prior to analysis, data was 
edited, coded, entered, and cleaned in Microsoft excel [24]. Survival 
analysis was conducted by checking the assumption of proportional 
hazards (PH), bi-variable and multivariable analysis. PH assumption 
was determined by Kaplan-Meier curves [25]. For those variables 
which fulfilled the PH assumption, bi-variable cox regression analysis 
was performed [26, 27]. All variables with p <0.25 on bi-variable 
analysis were then entered into multivariable analysis. Four models 
were constructed based on the key variables and a model was 
selected by looking at p value and smallest Bayesian information 
criteria. This study was approved by the Ethics Committee of Medical 
and Health Research, Faculty of Medicine, Public Health and Nursing, 
Universitas Gadjah Mada/Dr Sardjito Hospital, Yogyakarta, Indonesia 
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(reference number: KE/FK/690/EC/2015). Written informed and oral 
consent with digital recording were obtained during personal and 
telephone interviews to study participant or patient's relative. 
  
  
Results 
 
A total number of 213 eligible female patients with breast cancer were 
recruited. Thirty patients (14.1%) were known to be alive five years 
after their diagnosis. The survival status of the remaining 183 patients 
(85.9%) is unknown or lost during the follow-up. Table 1 displays the 
key socio-demographic and clinicopathologic characteristics of all the 
patients. Nearly half of them (105, 49.3%) were aged < 50 years. As 
many as 86 (40.4%) and 44 patients (20.7%) were married and 
employed. One fifth of them (43, 20.2%) had completed a high school 
education or above. A family history of breast cancer was reported 
among 25 (11.7%) patients. Most of all cases (151, 70.9%) were 
presented in the advanced stage of disease at the time of diagnosis, 
with tumor size of ≥5cm (90, 42.3%). Invasive ductal carcinoma was 
the most frequent histological diagnosis (182, 85.4%) and the cancer 
location was central in 61 patients (28.7%). As many as 66 patients 
(31.0%) had comorbidities and more than half of the cases (125, 
58.7%) underwent surgical intervention. Eighty percent of the 
patients (183) were censored due to failing to follow-up. Death was 
reported for 21 patients (9.9%) and 9 patients (4.2%) were reported 
as still being alive. The survival probability of breast cancer patients 
at the end of the five-year follow-up was 51.07%. In the bi-variable 
analysis, patients aged < 50 years, with a below high school 
education, advanced stage cancer, bigger tumor size, and central 
tumor location demonstrated a statistically significant worse five-year 
OS than their counterparts (p = 0.005, 0.001, 0.004, 0.011, and 
0.023, respectively) (Table 2). In the multivariable analysis, four main 
models were constructed with a combination of three variables (age 
at diagnosis, clinical stage, and tumor size). From the four models, 
the combinations of age at diagnosis and tumor size were selected 
(Table 3). Finally, it was found that younger cases had a significantly 
increased probability of mortality compared to the older patients 
(Figure 1) (HR = 3.73; 95% confidence interval/CI = 1.0-13.6, p = 
0.046). 
  
  
Discussion 
 
Survival of breast cancer in Indonesian patients is not very frequently 
analyzed. Indeed, some previous reports have come from our local 
institution. Aryandono et al. (2006) determined prognostic factors in 
operable patients and selected cases [8, 9]. Another publication by 
Widodo et al. (2017) recently showed prognostic determinants for 
patients diagnosed in 2008-2013 with different molecular types [22]. 
Also recently, a study from another institution identified a relationship 
between disease free survival and OS rates with the duration of 
targeted therapy in HER-2 positive operable patients [23]. However, 
those studies recruited only selected patients in different cohorts. Our 
present study analyzed a whole cohort of subjects, diagnosed in 2009, 
to see the patients' five-year OS regardless of their clinical stage and 
pathological characters. Exclusion was only done for subjects with 
very minimal data. Our findings showed that the five-year OS rate of 
local breast cancer patients was 51.07%. This was similar to those 
reported in India (52%), Brazil (58%), Uganda (46%), and Malaysia 
(49%). Nevertheless, this rate was much lower than those reported 
in developed countries, such as China (82%), Korea (79%), Cuba 
(84%), and Costa Rica (70%) [28-30]. Estimated survival rates vary 
according to the follow-up time period, the study population, the 
quality of the data, the statistical method used, and the possibility of 
biases. They are also affected by screening programs and the 
availability and accessibility of timely treatment. These suggest that 
the comparison of survival rates should be interpreted with caution 
[31]. Despite having data collected from many resources, the present 
study had a lot of missing information. As a consequence, many 
factors that might affect the survival rate, such as the precise follow-
up period and the completeness of the treatment could not be 
accurately determined. However, the data still laid a base for the 
study's conclusion and provided a general picture of the local 
situation. Just recently, Yogyakarta cancer registry has been 
developed to be part of the nationwide population-based cancer 
registry. In the future, data recording and data collection should be 
improved, which will provide better information for upcoming studies 
and advocation to the authorities for cancer management. One other 
reason that may influence the low survival rate in local patients is the 
fact that most of the cases were presented in an advanced stage at 
the baseline. This strongly emphasizes the need for a screening 
program among the local women. As suggested by Shulman et 
al. early detection by screening, which is subsequently followed by 
appropriate treatment, is needed to increase the survival rate of 
patients [32]. 
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In the bi-variable analysis, the present study demonstrated that 
patients with a lower education level, a more advanced stage of 
cancer, a bigger tumor, and a central tumor location were at a higher 
risk of mortality. The level of education has an influence on the 
knowledge and behavior of the patients. Patients with a good 
education tend to have a better comprehension of a variety of 
information and hence better knowledge and favorable behavior [11]. 
Similarly, the clinical stage of breast cancer and tumor size at the time 
of diagnosis are indeed important prognostic factors affecting survival 
[8, 9, 17, 18]. Tumor volume indicates the spread of the disease into 
surrounding areas and larger tumors show greater chances of 
spreading to other areas [33]. This is clinically often associated with 
a palpable regional lymph node. In addition, large tumors are 
frequently linked with a higher risk of relapse, irrespective of the 
lymph node status. Likewise, centrally located tumors have the 
tendency to spread to internal organs through local lymph nodes and 
correlate with a poor prognosis [16]. Many cohorts have observed 
that younger age is an independent predictor of an unfavorable 
treatment response, more aggressive tumor behavior, and a 
decreased survival rate [7-10, 34]. Younger women with breast 
cancer have a high tumor grade, clinically are more aggressive, 
present in an advanced stage, and have a high risk of recurrence 
[7, 10, 35]. Tumors in younger women tend to be negative for 
hormone receptors, and thus show a poor response to adjuvant 
therapy [7]. Supporting those findings, our study found that being < 
50 years old at the baseline was associated with an increased risk of 
mortality. Eventually, age was the only independent prognostic 
variable for the patient's five-year OS in the multivariable analysis. In 
contrast, other studies found that elderly women with breast cancer 
also have poor outcomes [16, 19, 36]. Differences in the subjects' 
characteristics across multiple studies may provide some reasons for 
these disagreements. 
  
  
Conclusion 
 
The five-year OS of breast cancer patients in the local tertiary hospital 
was 51.07%, which is relatively low compared to the survival of 
patients in developed countries. Screening implementation, an 
improved diagnostic approach, and increased access to treatment 
must be made available to enhance the survival of our local patients. 
Among many prognostic factors, age at diagnosis was the only 
significant predictor for the survival outcome, indicating that younger 
cases may need more attention and more aggressive treatment 
compared to older people. This also demands further studies to 
explore the risk factors in the local population, in particular in relation 
to their age. 
  
What is known about this topic 
 Breast cancer is the most prevalent cancer in Indonesia; 
 Some studies showed the survival of Indonesian patients 
with breast cancer in selected population. 
What this study adds 
 This study showed survival of all patients of a tertiary 
hospital in Indonesia diagnosed in 2009 (without 
selection); 
 Age, educational status, stage, tumor size and tumor 
location are factors affecting the five-year overall survival; 
 Age is found as independent prognostic factor for the 
overall survival. 
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Table 1: characteristics of patients with breast 
cancer 
Variables Frequency (%) 
Age 
 
≥50 years 104 (48.8) 
<50 years 105 (49.3) 
Missing data 4 (1.9) 
Marital Status 
 
Married 86 (40.4) 
Unmarried 5 (2.3) 
Missing data 122 (57.3) 
Education 
 
High school and above 43 (20.2) 
Below high school 25 (11.7) 
Missing data 145 (68.1) 
Family history of breast 
cancer 
 
Yes 25 (11.7) 
No 25 (11.7) 
Missing data 163 (76.6) 
Stage 
 
Advanced stage 151 (70.9) 
Early stage 38 (17.8) 
Missing data 24 (11.3) 
Tumor Size 
 
≥5 cm 90 (42.3) 
<5 cm 50 (23.5) 
Missing data 73 (34.2) 
Histology type 
 
Invasive ductal carcinoma 182 (85.4) 
Invasive lobular and other 
carcinoma 
13 (6.1) 
Missing data 18 (8.5) 
Tumor location 
 
Central 61 (28.7) 
Periphery         42 (19.7) 
Missing data 110 (51.6) 
Comorbidity 
 
Yes 66 (31.0) 
No 10 (4.7) 
Missing data 137 (64.3) 
Surgical intervention 
 
Yes 125 (58.7) 
No 67 (31.5) 
Missing data 21 (9.8) 
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Table 2: bi-variable analysis for survival of patients with breast cancer 
Variables Frequency (%) HR (95% CI) P value 
Age 
   
≥50 years 104 (48.8) 1.0 (ref) 0.005 
<50 years 105 (49.3) 3.6 (1.3-9.10) 
 
Missing data 4 (1.9) 
  
Marital Status 
   
Married 86 (40.4) 1.0 (ref) 0.105 
Unmarried 5 (2.3) 5.04 (0.6-44.5) 
 
Missing data 122 (57.3) 
  
Education 
   
High school and above 43 (20.2) 1.0 (ref) 0.001 
Below high school 25 (11.7) 5.31 (1.8-15.8) 
 
Missing data 145 (68.1) 
  
Family history of breast 
cancer 
   
Yes 25 (11.7) 1.0 (ref) 0.690 
No 25 (11.7) 1.25 (0.3-4.7) 
 
Missing data 163 (76.6) 
  
Stage 
   
Advanced stage 151 (70.9) 1.0 (ref) 0.004 
Early stage 38 (17.8) 0.16 (0.04-0.7) 
 
Missing data 24 (11.3) 
  
Tumor size 
   
≥5 cm 90 (42.3) 1.0 (ref) 0.011 
<5 cm 50 (23.5) 0.19 (0.04-0.9) 
 
Missing data 73 (34.2) 
  
Histology type 
   
Invasive ductal carcinoma 182 (85.4) 1.0 (ref) 0.614 
Invasive lobular and other 
carcinoma 
13 (6.1) 1.47 (0.3-6.7) 
 
Missing data 18 (8.5) 
  
Tumor location 
   
Central 61 (28.7) 1.0 (ref) 0.023 
Periphery 42 (19.7) 0.23 (0.1-0.9) 
 
Missing data 110 (51.6) 
  
Comorbidity 
   
Yes 66 (31.0) 1.0 (ref) 0.296 
No 10 (4.7) 2.34 (0.5-12.2) 
 
Missing data 137 (64.3) 
  
Surgical intervention 
   
Yes 125 (58.7) 1.0 (ref) 0.519 
No 67 (31.5) 1.47 (0.4-5.1) 
 
Missing data 21 (9.8) 
  
HR: hazard ratio; CI: confidence interval 
Table 3: multivariable analysis of various factors associated with survival of patients with breast cancer 
Variable Model 1 Model 2 Model 3 Model 4* 
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value 
Stage 0.29 (0.0-2.7) 0.279 0.24 (0.1-1.1) 0.065 0.16 (0.0-1.3) 0.089 - 
Age at diagnosis 2.66 (0.7-10.4) 0.160 2.71 (0.9-7.6) 0.059 - 3.73 (1.0-13.6) 0.046 
Tumor size 0.36 (0.1-1.7) 0.204 - 0.35 (0.1-1.7) 0.194 0.29 (0.1-1.4) 0.124 
BIC 106.27 152.55 103.85 104.54 
HR: hazad ratio; CI: confidence interval; BIC: Bayesian information criteria  *final model 
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Figure 1: Kaplan-Meier plot comparing five-year overall survival (OS) between patients with breast cancer aged ≥50 years 
and <50 years (HR = 3.73; 95% CI = 1.0-13.6, p = 0.046) 
 
